Home/Filings/4/0001209191-21-036302
4//SEC Filing

LEPORE PATRICK G 4

Accession 0001209191-21-036302

CIK 0001566044other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 5:18 PM ET

Size

5.3 KB

Accession

0001209191-21-036302

Insider Transaction Report

Form 4
Period: 2021-05-26
Transactions
  • Purchase

    Common Stock

    2021-05-26$3.60/sh+12,500$44,95837,500 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.48 to $3.6950, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001055404

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:18 PM ET
Size
5.3 KB